92
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Chemical Analysis and Antioxidant Activity of Essential Oils of Two Morphotypes of Lippia alba (Mill.) N.E. Br. ex Britton & P. Wilson (Verbenaceae)

, , , &
Pages 687-700 | Received 12 Sep 2017, Accepted 21 May 2018, Published online: 31 Jul 2018
 

Abstract

Lippia alba (Mill.) N.E.Br.ex Britton & P.Wilson is an aromatic shrub of Verbenaceae family. L. alba exhibits variability among its different accessions, showing difference in morphology and in the composition of essential oil. The objective of this study was to chemically characterize and evaluate the antioxidant activity of essential oil of two L. alba morphotypes. The essential oils were isolated by hydrodistillation using a Clevenger apparatus and the identification was done through GC/GC-MS analysis. The antioxidant activity was evaluated using DPPH radical scavenging, Iron chelating activity, FRAP assay, Super oxide radical scavenging and Nitric oxide radical scavenging activity. More than eighty constituents were identified in both the oil's. Both the oils were characterized by a high amount of oxygenated monoterpenes (80.8%) and (82.0%). The major constituent in both the morphotypes was linalool. The other major constituents found in type-I were eucalyptol (4.2%), neral (1.1%), geranial (1.5%), E-caryophyllene (3.1%), germacrene-D (3.3%), germacrene-B (1.6%), 3E,5E-2,6-dimethyl-3,5,7-octatriene-2-ol (2.1%), 3E,5Z-2,6-dimethyl-3,5,7-octatriene-2-ol (3.8%) whereas in type-II were eucalyptol (4.7%), β-citronellol (1.3%), neral (2.3%), geranial (2.8%), β-caryophyllene (2.3%), germacrene-D (3.0%), germacrene-B (1.4%), carryophyllene oxide (1.1%), 3E,5E-2,6-dimethyl-3,5,7-octatriene-2-ol (1.6%), 3E,5Z-2,6-dimethyl-3,5,7-octatriene-2-ol (2.9%). Both the morphotypes exhibited good antioxidant activity but the activity, was found higher in type-II L. alba morphotype than type-I. The chemical composition and antioxidant activity suggest L. alba as a potential source of natural linalool and further its use in ethanopharmacological applications.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.